FDA allows 3-year shelf life for CSL Behring's Privigen

04/22/2010 | Medscape (free registration)

The FDA approved a one-year extension for the shelf life of CSL Behring's 10% liquid intravenous immunoglobulin injection, or Privigen. The change allows the product to be stored at room temperature for three years. The approval was based on a study showing that the immunoglobulin G fraction's purity remains high when the intravenous immunoglobulin product is stored in a controlled environment.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL